Literature DB >> 9272158

Progressive familial intrahepatic cholestasis (PFIC): evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21-q22.

H Arnell1, A Nemeth, G Annerén, N Dahl.   

Abstract

Progressive familial intrahepatic cholestasis (PFIC) is the second most common form of familial intrahepatic cholestasis. The genes for PFIC and for a milder form of the disease, benign recurrent intrahepatic cholestasis (BRIC), were recently mapped to a 19-cM region on chromosome 18q21-q22. The results suggest that PFIC and BRIC are allelic diseases. We have studied 11 Swedish patients from eight families with clinical and biochemical features consistent with PFIC. The families were genotyped for markers D18S69, D18S64, D18S55 and D18S68, spanning the PFIC candidate region. Unexpectedly, the segregation of haplotypes excluded the entire region in three families, and no indications for shared haplotypes were found in the patients of the six remaining families. A four-point linkage analysis of all families excluded linkage from D18S69 to D18S55 (Zmax < -5). Thus, our data strongly suggest the presence of a second, yet unknown, locus for PFIC. The results indicate that great care should be taken when using 18q markers for prenatal diagnosis and genetic counseling for the disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9272158     DOI: 10.1007/s004390050519

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  6 in total

Review 1.  The molecular genetics of familial intrahepatic cholestasis.

Authors:  P L Jansen; M Müller
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

2.  A novel heterozygous NR1H4 termination codon mutation in idiopathic infantile cholestasis.

Authors:  Xiu-Qi Chen; Lin-Lin Wang; Qing-Wen Shan; Qing Tang; Ya-Nan Deng; Shu-Jun Lian; Xiang Yun
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

3.  A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian childhood cirrhosis.

Authors:  Pierre Chagnon; Jacques Michaud; Grant Mitchell; Jocelyne Mercier; Jean-François Marion; Eric Drouin; Andrée Rasquin-Weber; Thomas J Hudson; Andrea Richter
Journal:  Am J Hum Genet       Date:  2002-11-04       Impact factor: 11.025

Review 4.  Progressive familial intrahepatic cholestasis.

Authors:  Anshu Srivastava
Journal:  J Clin Exp Hepatol       Date:  2013-11-23

5.  Multidrug resistance protein 3 R652G may reduce susceptibility to idiopathic infant cholestasis.

Authors:  Xiu-Qi Chen; Lin-Lin Wang; Qing-Wen Shan; Qing Tang; Shu-Jun Lian
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

6.  Apolipoprotein E polymorphism in alagille syndrome and progressive familial intrahepatic cholestasis.

Authors:  P Socha; G Nowicka; I Jankowska; J Rujner; J Pawłowska; J Socha
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.